Vincristine-induced overexpression of P-glycoprotein in L1210 cells is associated with remodeling of cell surface saccharides

Journal of Proteome Research

Volumn 8, Issue 2, 2009, Pages 513-520

  Sulová, Zdenka ^a   Mlslovičová, Danica ^b   Gibalová, Lenka ^a   Vajčnerová, Zuzana ^b   Polákov́, Eva ^a   Uhrík, Branislav ^a   Tyiková, Lucia ^a   Kovárová, Annamária ^b   Sedlák, Ján ^c   Breier, Albert ^a  

^a INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c CANCER RESEARCH INSTITUTE   (Slovakia)

Author keywords

Cell surface saccharides; Concanavalin A; L1210 cell line; Lycopersicum esculentum agglutinin; Multidrug resistance; p glycoprotein

Indexed keywords

CARBOHYDRATE DERIVATIVE; CONCANAVALIN A; GLYCOPROTEIN P; LECTIN; N ACETYLGLUCOSAMINE; VINCRISTINE;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL DAMAGE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; GLYCOSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; CONCANAVALIN A; DRUG RESISTANCE, MULTIPLE; MICE; P-GLYCOPROTEIN; PLANT LECTINS; POLYSACCHARIDES; VINCRISTINE;

LYCOPERSICON ESCULENTUM; MURINAE;

EID: 61849177588     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr8007094     Document Type: Article

References (41)

1. Sharom, F. J. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 2008, 9 (1), 105-127.
2. Kvackajova-Kisucka, J.; Barancik, M.; Breier, A. Drug transporters and their role in multidrug resistance of neoplastic cells. Gen. Physiol Biophys. 2001, 20 (3), 215-237.
3. Bosch, T. M. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy. Methods Mol. Biol. 2008, 448, 63-76.
4. Inoue, S.; Salah-Eldin, A. E.; Omoteyama, K. Apoptosis and anticancer drug resistance. Hum. Cell. 2001, 14 (3), 211-221.
5. Pawagi, A. B.; Wang, J.; Silverman, M.; Reithmeier, R. A.; Deber, C. M. Transmembrane aromatic amino acid distribution in P-glycoprotein. A functional role in broad substrate specificity. J. Mol. Biol. 1994, 235 (2), 554-564.
6. Didziapetris, R.; Japertas, P.; Avdeef, A.; Petrauskas, A. Classification analysis of P-glycoprotein substrate specificity. J. Drug Target 2003, 11 (7), 391-406.
7. Breier, A.; Barancik, M.; Sulova, Z.; Uhrik, B. P-glycoprotein- implications of metabolism of neoplastic cells and cancer therapy. Curr. Cancer Drug Targets 2005, 5 (6), 457-468.
8. Polekova, L.; Barancik, M.; Mrazova, T.; Pirker, R.; Wallner, J.; Sulova, Z.; Breier, A. Adaptation of mouse leukemia cells L1210 to vincristine. Evidence for expression of P-glycoprotein. Neoplasma 1992, 39 (2), 73-77.
9. Fiala, R.; Sulova, Z.; El-Saggan, A. H.; Uhrik, B.; Liptaj, T.; Dovinova, I.; Hanusovska, E.; Drobna, Z.; Barancik, M.; Breier, A. P-glycoprotein- mediated multidrug resistance phenotype of L1210/VCR cells is associated with decreases of oligo- and/or polysaccharide contents. Biochim. Biophys. Acta 2003, 1639 (3), 213-224.
10. Bohacova, V.; Kvackajova, J.; Barancik, M.; Drobna, Z.; Breier, A. Glutathione S-transferase does not play a role in multidrug resistance of L1210/VCR cell Une. Physiol. Res. 2000, 49 (4), 447-453.
11. Bohacova, V.; Sulova, Z.; Dovinova, I.; Polakova, E.; Barancik, M.; Uhrik, B.; Orlicky, J.; Breier, A. L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein. Toxicol, in Vitro 2006, 20 (8), 1560-1568.
12. Szubinska, B.; Luft, J. H. Ruthenium red and violet 3. Fine structure of the plasma membrane and extraneous coats in amoebae (A. proteus and Chaos chaos). Anat. Rec. 1971, 171 (3), 417-441.
13. Potapov, M. I. Lectinology as a section of forensic medical serology. Sud. Med. Ekspert 2006, 49 (1), 17-19.
14. Gabius, H. J. Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer. Crit. Rev. Immunol 2006, 26 (1), 43-79.
15. Gabius, H. J.; Gabius, S. [Tumor lectinology-status and perspectives of clinical application]. Naturwissenschaften 1990, 77 (11), 505-514.
16. Csuka, O.; Sugar, J. Cell surface properties of L1210 leukaemia cells. Acta Morphol. Acad. Sci. Hung. 1976, 24 (4), 297-305.
17. Fakla, I.; Hever, A.; Molnar, J.; Fischer, J. Tomato lectin labels the 180 kD glycoform of P-glycoprotein in rat brain capillary endothelia and mdr tumor cells. Anticancer Res. 1998, 18 (4C), 3107- 3111.
18. Walther, W.; Stein, U. Influence of cytokines on mdrl expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs. J. Cancer Res. Clin. Oncol 1994, 120 (8), 471-478.
19. Stein, U.; Walther, W.; Shoemaker, R. H. Modulation of mdrl expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance. Br. J. Cancer 1996, 74 (9), 1384-1391.
20. Noonan, K. E.; Beck, C.; Holzmayer, T. A.; Chin, J. E.; Wunder, J. S.; Andrulis, I. L.; Gazdar, A. F.; Willman, C. L.; Griffith, B.; Von Hoff, D. D., Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. U.SA. 1990, 87 (18), 7160-7164.
21. Wu, L.; Smythe, A. M.; Stinson, S. F.; Mullendore, L. A.; Monks, A.; Scudiero, D. A.; Pauli, K. D.; Koutsoukos, A. D.; Rubinstein, L. V.; Boyd, M. R., Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res. 1992, 52 (11), 3029-3034.
22. Hamada, H.; Tsuruo, T. Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170- to 180-kilodalton membrane glycoprotein is an ATPase. J. Biol. Chem. 1988, 263 (3), 1454-1458.
23. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227 (5259), 680- 685.
24. Towbin, H.; Staehelin, T.; Gordon, J. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.SA. 1979, 76 (9), 4350-4354.
25. Sulova, Z.; Macejova, D.; Seres, M.; Sedlak, J.; Brtko, J.; Breier, A. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. Toxicol. in Vitro 2008, 22 (1), 96-105.
26. Rupley, J. A. The hydrolysis of chitin by concentrated hydrochloric acid, and the preparation of low-molecular-weight substrates for lysozyme. Biochim. Biophys. Acta 1964, 83, 245-255.
27. Gerlier, D.; Thomasset, N. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods 1986, 94 (1-2), 57- 63.
28. Kupsakova, I.; Rybar, A.; Docolomansky, P.; Drobna, Z.; Stein, U.; Walther, W.; Barancik, M.; Breier, A. Reversal of P-glycoprotein mediated vincristine resistance of L1210/VCR cells by analogues of pentoxifylline. A QSAR study. Eur. J. Pharm. Sci. 2004, 21 (2- 3), 283-293.
29. Barancik, M.; Bohacova, V.; Zbynovcova, M.; Breier, A. Differential expression of regulatory proteins in L1210/VCR cells with multidrug resistance mediated by P-glycoprotein. Gen. Physiol. Biophys. 1999, 18 (1), 45-56.
30. Barancik, M.; Bohacova, V.; Kvackajova, J.; Hudecova, S.; Krizanova, O.; Breier, A. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance. Eur. J. Pharm. Sci. 2001, 14 (1), 29-36.
31. Kisucka, J.; Barancik, M.; Bohacova, V.; Breier, A. Reversal effect of specific inhibitors of extracellular-signal regulated protein kinase pathway on P-glycoprotein mediated vincristine resistance of L1210 cells. Gen. Physiol. Biophys. 2001, 20 (4), 439-444.
32. Barancik, M.; Bohacova, V.; Sedlak, J.; Sulova, Z.; Breier, A. LY294.002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance. Eur. J. Pharm. Sci. 2006, 29 (5), 426-434.
33. Sulova, Z.; Orlicky, J.; Fiala, R.; Dovinova, I.; Uhrik, B.; Seres, M.; Gibalova, L.; Breier, A. Expression of P-glycoprotein in L1210 cells is linked with rise in sensitivity to Ca2+. Biochem. Biophys. Res. Commun. 2005, 335 (3), 777-784.
34. Seres, M.; Polakova, E.; Krizanova, O.; Hudecova, S.; Klymenko, S. V.; Breier, A.; Sulova, Z. Overexpression of P-glycoprotein in L1210/VCR cells is associated with changes in several endoplasmic reticulum proteins that may be partially responsible for the lack of thapsigargin sensitivity. Gen. Physiol. Biophys. 2008, 27 (3), 211-221.
35. Greer, D. A.; Ivey, S. Distinct N-glycan glycosylation of P-glycoprotein isolated from the human uterine sarcoma cell line MES- SA/Dx5. Biochim. Biophys. Acta 2007, 1770 (9), 1275-1282.
36. De Mejia, E. G.; Prisecaru, V. I. Lectins as bioactive plant proteins: a potential in cancer treatment. Crit. Rev. Food Sci. Nutr. 2005, 45 (6), 425-445.
37. Sharon, N. Lectins: carbohydrate-specific reagents and biological recognition molecules. J. Biol. Chem. 2007, 282 (5), 2753-2764.
38. Sulova, Z.; Mislovicova, D.; Gibalova, L.; Polakova, E.; Breier, A. Overexpression of P-glycoprotein in L1210 cells is associated with alternation in cell surface glycosides. FEBS J. 2008, 275 (Suppl. 1), 345-345.
39. Rudiger, H.; Gabius, H. J. Plant lectins: occurrence, biochemistry, functions and applications. Glycoconjugate J. 2001, 18 (8), 589- 613.
40. Kilpatrick, D. C. Purification and some properties of a lectin from the fruit juice of the tomato (Lycopersicon esculentum). Biochem. J. 1980, 185 (1), 269-272.
41. Kulkarni, G. V.; McCulloch, C. A Concanavalin A induced apoptosis in fibroblasts: the role of cell surface carbohydrates in lectin mediated cytotoxicity. J. Cell. Physiol. 1995, 165 (1), 119-133.